L. Prix

Addition of Multimodal Immunotherapy to Combination Treatment Strategies for Children with DIPG: A Single Institution Experience

S. V. Van Gool, J. Nazarian, V. Schirrmacher, 2020, Medicines.

Drug-resistant human cytomegalovirus infection in children after allogeneic stem cell transplantation may have different clinical outcomes.

T. Klingebiel, T. Eckle, R. Handgretinger, 2000, Blood.

Rapid development of ganciclovir-resistant cytomegalovirus infection in children after allogeneic stem cell transplantation in the early phase of immune cell recovery

T. Klingebiel, T. Eckle, R. Handgretinger, 2002, Bone Marrow Transplantation.

A simplified assay for screening of drug resistance of cell-associated cytomegalovirus strains.

G. Jahn, K. Hamprecht, J. Maierl, 1998, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Randomized Controlled Immunotherapy Clinical Trials for GBM Challenged

S. V. Van Gool, V. Schirrmacher, J. Makalowski, 2020, Cancers.

Diagnostic biochip array for fast and sensitive detection of K-ras mutations in stool.

Andreas J. Schuetz, P. Uciechowski, M. Giesing, 2002, Clinical chemistry.

Biochip for K-ras mutation screening in ovarian cancer.

Andreas J. Schuetz, R. Zeillinger, G. Fabjani, 2005, Clinical chemistry.

Comprehensive restriction analysis of the UL97 region allows early detection of ganciclovir-resistant human cytomegalovirus in an immunocompromised child.

T. Klingebiel, R. Handgretinger, G. Jahn, 1999, The Journal of infectious diseases.

Ganciclovir-resistant cytomegalovirus disease after allogeneic stem cell transplantation: pitfalls of phenotypic diagnosis by in vitro selection of an UL97 mutant strain.

H. Einsele, T. Eckle, G. Jahn, 2003 .

Evaluation of restriction fragment length polymorphism analysis of the UL10-UL13 genomic region for rapid identification of human cytomegalovirus strains

R. Kuner, G. Jahn, C. Speer, 1998, European Journal of Clinical Microbiology and Infectious Diseases.